English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/111468
COMPARTIR / IMPACTO:
Estadísticas
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Título

Predicting targets of compounds against neurological diseases using cheminformatic methodology

AutorNikolic, Katarina; Mavridis, L.; Bautista-Aguilera, Oscar M.; Marco-Contelles, José ; Stark, H.; do Carmo Carreiras, María; Rossi, I.; Massarelli, P.; Agbaba, Danica; Ramsay, Rona R.; Mitchell, J. B. O.
Palabras claveChE
Circular fingerprints
Off-target study
MAO
Histamine H3 receptor
Multi-targeted ligands
HMT
Fecha de publicación2015
EditorKluwer Academic Publishers
CitaciónJournal of Computer-Aided Molecular Design 29: 183- 198 (2015)
ResumenRecently developed multi-targeted ligands are novel drug candidates able to interact with monoamine oxidase A and B; acetylcholinesterase and butyrylcholinesterase; or with histamine N-methyltransferase and histamine H3-receptor (H3R). These proteins are drug targets in the treatment of depression, Alzheimer's disease, obsessive disorders, and Parkinson's disease. A probabilistic method, the Parzen-Rosenblatt window approach, was used to build a >predictor> model using data collected from the ChEMBL database. The model can be used to predict both the primary pharmaceutical target and off-targets of a compound based on its structure. Molecular structures were represented based on the circular fingerprint methodology. The same approach was used to build a >predictor> model from the DrugBank dataset to determine the main pharmacological groups of the compound. The study of off-target interactions is now recognised as crucial to the understanding of both drug action and toxicology. Primary pharmaceutical targets and off-targets for the novel multi-target ligands were examined by use of the developed cheminformatic method. Several multi-target ligands were selected for further study, as compounds with possible additional beneficial pharmacological activities. The cheminformatic targets identifications were in agreement with four 3D-QSAR (H3R/D1R/D2R/5-HT2aR) models and by in vitro assays for serotonin 5-HT1a and 5-HT2a receptor binding of the most promising ligand (71/MBA-VEG8).
URIhttp://hdl.handle.net/10261/111468
DOI10.1007/s10822-014-9816-1
Identificadoresdoi: 10.1007/s10822-014-9816-1
issn: 0920-654X
e-issn: 1573-4951
Aparece en las colecciones: (IQOG) Artículos
(IQM) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
accesoRestringido.pdf15,38 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo
 

Artículos relacionados:


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.